Episode Details
Back to Episodes
Pharmaceutical Executive Daily: September 29, 2025
Published 7 months, 3 weeks ago
Description
In today’s Pharmaceutical Executive Daily, we cover the impact of Novo Nordisk layoffs on its hometown in Denmark, GSK’s appointment of Luke Miels as its next CEO, and the FDA’s approval of Regeneron’s Evkeeza for children with homozygous familial hypercholesterolemia.